Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? - PubMed
- ️Tue Jan 01 2008
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Ekaterina S Jordanova et al. Clin Cancer Res. 2008.
Abstract
Purpose: To investigate the effect of intraepithelial tumor-infiltrating lymphocytes (ieTIL) and their ligands expressed by cervical tumor cells on the outcome of cervical cancer patients.
Experimental design: The prognostic value of ieTILs was investigated in 115 cases of cervical cancer. T-cell subsets, CD57(+) cells, and regulatory T cells (Treg) were enumerated. The associations of these different ieTIL subtypes with human leukocyte antigen (HLA) class I and MHC class I chain-related molecule A (MICA) expression were determined in relation to clinical variables and patient survival.
Results: Survival analysis showed that a high number of intraepithelial Treg (FoxP3(+)), a low CD8(+)/regulatory T-cell ratio, and a weak HLA-A expression were all associated with worse survival (P=0.034, 0.025, and 0.033, respectively, log-rank test). Further stratification of patient groups based on HLA-A-MICA expression and HLA-A-MICA-CD8(+)/Treg ratio revealed an even poorer survival (P=0.005). In a multivariate Cox analysis, low CD8(+)/Treg ratio (P=0.047), weak HLA-A-MICA expression (P=0.003), and weak HLA-A-MICA expression combined with low CD8(+)/Treg ratio (P=0.002) were all found to be independent unfavorable prognostic predictors in cervical carcinoma (hazard ratios, 2.7, 4.0, and 4.9, respectively).
Conclusion: Weak HLA-A-MICA expression combined with low CD8(+)/Treg ratio reveals a patient group with the poorest survival in cervical cancer. As a single variable, low CD8(+)/Treg ratio was a significant independent unfavorable prognostic factor.
Similar articles
-
Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Cai MY, et al. Clin Cancer Res. 2009 Jul 15;15(14):4686-93. doi: 10.1158/1078-0432.CCR-09-0463. Epub 2009 Jul 7. Clin Cancer Res. 2009. PMID: 19584149
-
de Kruijf EM, van Nes JG, Sajet A, Tummers QR, Putter H, Osanto S, Speetjens FM, Smit VT, Liefers GJ, van de Velde CJ, Kuppen PJ. de Kruijf EM, et al. Clin Cancer Res. 2010 Feb 15;16(4):1272-80. doi: 10.1158/1078-0432.CCR-09-1844. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145162
-
Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B. Salama P, et al. J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064967
-
The significance of Treg cells in defective tumor immunity.
Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I. Kosmaczewska A, et al. Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):181-91. doi: 10.1007/s00005-008-0018-1. Epub 2008 May 30. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18512029 Review.
-
Specific control of immunity by regulatory CD8 T cells.
Tang XL, Smith TR, Kumar V. Tang XL, et al. Cell Mol Immunol. 2005 Feb;2(1):11-9. Cell Mol Immunol. 2005. PMID: 16212906 Review.
Cited by
-
Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer.
Zhang Y, Yu M, Jing Y, Cheng J, Zhang C, Cheng L, Lu H, Cai MC, Wu J, Wang W, Lou W, Qiu L, Tan L, Lu H, Yin X, Zhuang G, Di W. Zhang Y, et al. Br J Cancer. 2021 Jan;124(2):414-424. doi: 10.1038/s41416-020-01123-w. Epub 2020 Oct 22. Br J Cancer. 2021. PMID: 33087896 Free PMC article.
-
Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis.
Kwiatkowska I, Hermanowicz JM, Przybyszewska-Podstawka A, Pawlak D. Kwiatkowska I, et al. Cancers (Basel). 2021 May 28;13(11):2667. doi: 10.3390/cancers13112667. Cancers (Basel). 2021. PMID: 34071442 Free PMC article. Review.
-
Hu J, Wu X, Huang P, Teng F, Wang Y, Xue F. Hu J, et al. J Cancer. 2020 Mar 5;11(11):3340-3348. doi: 10.7150/jca.42472. eCollection 2020. J Cancer. 2020. PMID: 32231740 Free PMC article.
-
Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW. Gooden MJ, et al. Br J Cancer. 2011 Jun 28;105(1):93-103. doi: 10.1038/bjc.2011.189. Epub 2011 May 31. Br J Cancer. 2011. PMID: 21629244 Free PMC article. Review.
-
Nejati R, Goldstein JB, Halperin DM, Wang H, Hejazi N, Rashid A, Katz MH, Lee JE, Fleming JB, Rodriguez-Canales J, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang H. Nejati R, et al. Pancreas. 2017 Oct;46(9):1180-1187. doi: 10.1097/MPA.0000000000000914. Pancreas. 2017. PMID: 28902789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials